Healio

Regimen ‘one of the best options’ for locally advanced rectal cancer

Please provide your email address to receive an email when new articles are posted on . The addition of modified FOLFIRINOX induction chemotherapy to standard care improved metastasis-free survival.
Healio

Neoadjuvant chemotherapy regimen shows durable survival benefit in rectal cancer

Please provide your email address to receive an email when new articles are posted on . Seven-year estimates favored the neoadjuvant FOLFIRINOX group vs. the standard-of-care group for all survival ...
Business Insider

Rafael Pharmaceuticals Announces Initiation of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 (devimistat) in Combination with Modified FOLFIRINOX as First Line Treatment for ...

Newark, NJ, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael), a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a phase 3 ...
Nasdaq

Immuneering Updates On Positive Phase 2a Results For IMM-1-104 With Modified FOLFIRINOX

(RTTNews) - Immuneering Corporation (IMRX), a Massachusetts-based biopharmaceutical company Monday announced a positive update from its Phase 2a study of IMM-1-104 combined with modified FOLFIRINOX ...